| Biological Sciences | Lifetime | 467 | US 282 | 99.94 |
| Genetics | Lifetime | 25 | US 12 | 99.94 |
| Molecular Biology | Lifetime | 701 | US 425 | 99.64 |
| Surgery | Lifetime | 886 | US 476 | 99.16 |
| Cardiology and Cardiovascular Medicine | Lifetime | 570 | US 303 | 99.08 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 380 | US 209 | 98.86 |
| Cancer Research | Lifetime | 864 | US 434 | 93.49 |
| Genetics | 2021-2025 | 216 | US 79 | 94.38 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 944 | US 417 | 79.39 |
| Genetic Associations and Epidemiology | Lifetime | 4 | US 2 | 99.95 |
| Nutrition, Genetics, and Disease | Lifetime | 17 | US 8 | 99.66 |
| Genomics and Rare Diseases | Lifetime | 26 | US 17 | 99.63 |
| Lipoproteins and Cardiovascular Health | Lifetime | 47 | US 29 | 99.72 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 61 | US 31 | 99.67 |
| Hormonal Regulation and Hypertension | Lifetime | 85 | US 37 | 99.45 |
| Lipid metabolism and disorders | Lifetime | 33 | US 20 | 99.31 |
| Bioinformatics and Genomic Networks | Lifetime | 67 | US 40 | 99.12 |
| RNA modifications and cancer | Lifetime | 413 | US 234 | 99.10 |
| Cancer, Lipids, and Metabolism | Lifetime | 209 | US 112 | 99.10 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 266 | US 112 | 98.39 |
| Genetic Mapping and Diversity in Plants and Animals | Lifetime | 194 | US 87 | 98.74 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 215 | US 97 | 98.30 |
| Renin-Angiotensin System Studies | Lifetime | 131 | US 57 | 98.37 |
| Blood Pressure and Hypertension Studies | Lifetime | 492 | US 206 | 98.57 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 331 | US 166 | 97.63 |
| Diet, Metabolism, and Disease | Lifetime | 580 | US 213 | 97.29 |
| Genomic variations and chromosomal abnormalities | Lifetime | 443 | US 198 | 97.09 |
| Folate and B Vitamins Research | Lifetime | 759 | US 363 | 95.31 |
| Cardiovascular Health and Disease Prevention | Lifetime | 982 | US 353 | 96.04 |
| Protease and Inhibitor Mechanisms | Lifetime | 861 | US 363 | 95.52 |
| Cardiovascular Health and Risk Factors | Lifetime | 445 | US 250 | 94.58 |
| Gene expression and cancer classification | Lifetime | 761 | US 392 | 94.40 |
| Machine Learning in Bioinformatics | Lifetime | 973 | US 278 | 89.98 |
| Genetics and Physical Performance | Lifetime | 459 | US 141 | 87.14 |
| Apelin-related biomedical research | Lifetime | 846 | US 232 | 84.84 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 746 | US 151 | 69.13 |
| Biological Research and Disease Studies | Lifetime | 140 | US 44 | 51.40 |
| Genetic Associations and Epidemiology | 2021-2025 | 258 | US 110 | 94.69 |
| Genomics and Rare Diseases | 2021-2025 | 356 | US 138 | 92.11 |
| Nutrition, Genetics, and Disease | 2021-2025 | 244 | US 71 | 84.31 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 494 | US 189 | 81.58 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 720 | US 336 | 79.52 |